Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
21.96
-0.19 (-0.86%)
Jun 10, 2026, 4:00 PM EDT
SHA:603207 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 643.48 | 647.59 | 883.43 | 285.54 | 58.66 | 44.81 |
Short-Term Investments | - | - | - | - | 1.31 | 5.08 |
Trading Asset Securities | 3 | - | - | 2.97 | 108.96 | 158.11 |
Cash & Short-Term Investments | 646.48 | 647.59 | 883.43 | 288.52 | 168.93 | 208.01 |
Cash Growth | -29.25% | -26.70% | 206.20% | 70.79% | -18.79% | 84.58% |
Accounts Receivable | 135.54 | 123.97 | 90.29 | 85.39 | 81.88 | 55.82 |
Other Receivables | 3.57 | 2.93 | 2.21 | 2.06 | 0.82 | 0.72 |
Receivables | 139.11 | 126.9 | 92.5 | 87.46 | 82.69 | 56.55 |
Inventory | 60.71 | 69.18 | 45.21 | 49.9 | 57.2 | 53.37 |
Other Current Assets | 36.62 | 16.19 | 10.8 | 26.19 | 19.04 | 8.45 |
Total Current Assets | 882.92 | 859.86 | 1,032 | 452.06 | 327.87 | 326.37 |
Property, Plant & Equipment | 349.43 | 349.22 | 338.04 | 226.57 | 62.97 | 25.75 |
Long-Term Investments | - | - | - | - | - | 1.27 |
Other Intangible Assets | 22.54 | 22.94 | 24.53 | 26.12 | 27.7 | 29.23 |
Long-Term Deferred Tax Assets | 5.41 | 4.8 | 3.36 | 2.86 | 2.27 | 2 |
Long-Term Deferred Charges | - | - | 1.32 | 0.47 | 0.49 | 0.74 |
Other Long-Term Assets | 1.1 | 2.65 | 3.26 | 4.58 | 42 | 0.67 |
Total Assets | 1,261 | 1,239 | 1,402 | 712.65 | 463.3 | 386.02 |
Accounts Payable | 40.3 | 38.99 | 23.09 | 19.61 | 27.42 | 16.61 |
Accrued Expenses | 7.43 | 37.08 | 36.34 | 38.38 | 28.91 | 34.34 |
Short-Term Debt | 6.35 | 1.12 | 1.65 | - | - | - |
Current Portion of Leases | 1.31 | 1.06 | 0.67 | 0.42 | - | - |
Current Income Taxes Payable | 13.62 | 6.09 | 7.13 | 5.33 | 12.5 | 13.71 |
Current Unearned Revenue | 7.12 | 6.97 | 0.89 | 0.61 | 1.55 | 11.79 |
Other Current Liabilities | 34.66 | 55.02 | 98.38 | 67.82 | 19.58 | 79.09 |
Total Current Liabilities | 110.79 | 146.34 | 168.15 | 132.18 | 89.96 | 155.55 |
Long-Term Leases | 0.04 | 0.32 | - | 0.44 | 0.88 | 1.27 |
Long-Term Unearned Revenue | 0.05 | 0.05 | 0.07 | 0.08 | 0.09 | 0.1 |
Total Liabilities | 110.88 | 146.71 | 168.21 | 132.7 | 90.94 | 156.92 |
Common Stock | 160.82 | 160.56 | 160 | 120 | 120 | 120 |
Additional Paid-In Capital | 493.91 | 489.09 | 478.23 | 69.22 | 65.25 | 61.18 |
Retained Earnings | 506.27 | 450.26 | 596.01 | 390.73 | 187.11 | 47.93 |
Treasury Stock | -10.47 | -7.15 | - | - | - | - |
Shareholders' Equity | 1,151 | 1,093 | 1,234 | 579.95 | 372.36 | 229.11 |
Total Liabilities & Equity | 1,261 | 1,239 | 1,402 | 712.65 | 463.3 | 386.02 |
Total Debt | 7.7 | 2.5 | 2.32 | 0.86 | 0.88 | 1.27 |
Net Cash (Debt) | 638.78 | 645.08 | 881.11 | 287.65 | 168.05 | 206.74 |
Net Cash Growth | -30.00% | -26.79% | 206.31% | 71.17% | -18.71% | 83.45% |
Net Cash Per Share | 3.98 | 4.01 | 6.57 | 2.40 | 1.40 | 1.72 |
Filing Date Shares Outstanding | 160.82 | 160.82 | 160.56 | 160 | 120 | 120 |
Total Common Shares Outstanding | 160.82 | 160.56 | 160 | 120 | 120 | 120 |
Working Capital | 772.13 | 713.52 | 863.79 | 319.89 | 237.9 | 170.83 |
Book Value Per Share | 7.15 | 6.81 | 7.71 | 4.83 | 3.10 | 1.91 |
Tangible Book Value | 1,128 | 1,070 | 1,210 | 553.84 | 344.66 | 199.88 |
Tangible Book Value Per Share | 7.01 | 6.66 | 7.56 | 4.62 | 2.87 | 1.67 |
Buildings | - | 13.22 | 26.35 | 26.35 | 26.35 | 25.62 |
Machinery | - | 41 | 36.94 | 35.52 | 35.19 | 32.62 |
Construction In Progress | - | 336.51 | 329.17 | 216.53 | 50.04 | 12.67 |